231 related articles for article (PubMed ID: 26944863)
1. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
[TBL] [Abstract][Full Text] [Related]
2. One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception.
Sanders JN; Turok DK; Royer PA; Thompson IS; Gawron LM; Storck KE
Contraception; 2017 Aug; 96(2):99-105. PubMed ID: 28596121
[TBL] [Abstract][Full Text] [Related]
3. Interventions for emergency contraception.
Shen J; Che Y; Showell E; Chen K; Cheng L
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD001324. PubMed ID: 28766313
[TBL] [Abstract][Full Text] [Related]
4. Choice of Emergency Contraceptive and Decision Making Regarding Subsequent Unintended Pregnancy.
Royer PA; Turok DK; Sanders JN; Saltzman HM
J Womens Health (Larchmt); 2016 Oct; 25(10):1038-1043. PubMed ID: 27032057
[TBL] [Abstract][Full Text] [Related]
5. Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.
Ramanadhan S; Goldstuck N; Henderson JT; Che Y; Cleland K; Dodge LE; Edelman A
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013744. PubMed ID: 36847591
[TBL] [Abstract][Full Text] [Related]
6. Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: Implications for backup contraception recommendations.
Fay KE; Clement AC; Gero A; Kaiser JE; Sanders JN; BakenRa AA; Turok DK
Contraception; 2021 Nov; 104(5):561-566. PubMed ID: 34166648
[TBL] [Abstract][Full Text] [Related]
7. Copper intrauterine device placement 6-14 days after unprotected sex.
Thompson I; Sanders JN; Schwarz EB; Boraas C; Turok DK
Contraception; 2019 Sep; 100(3):219-221. PubMed ID: 31176689
[TBL] [Abstract][Full Text] [Related]
8. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014-2016.
Linder M; Schoendorf J; Pisa F; Schulze-Rath R; Cesta CE
Contraception; 2024 Mar; 131():110309. PubMed ID: 37844683
[TBL] [Abstract][Full Text] [Related]
10. Placement of Levonorgestrel Intrauterine Device at the Time of Cesarean Delivery and the Effect on Breastfeeding Duration.
Levi EE; Findley MK; Avila K; Bryant AG
Breastfeed Med; 2018 Dec; 13(10):674-679. PubMed ID: 30376369
[No Abstract] [Full Text] [Related]
11. The Levonorgestrel-Releasing Intrauterine Device as Emergency Contraception: Re-examining the Data.
Ramanadhan S; Jensen J
Obstet Gynecol; 2024 Feb; 143(2):189-194. PubMed ID: 37989139
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.
Rowe P; Farley T; Peregoudov A; Piaggio G; Boccard S; Landoulsi S; Meirik O;
Contraception; 2016 Jun; 93(6):498-506. PubMed ID: 26916172
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy Risk by Frequency and Timing of Unprotected Intercourse Before Intrauterine Device Placement for Emergency Contraception.
BakenRa A; Gero A; Sanders J; Simmons R; Fay K; Turok DK
Obstet Gynecol; 2021 Jul; 138(1):79-84. PubMed ID: 34259467
[TBL] [Abstract][Full Text] [Related]
14. One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.
Kaiser JE; Turok DK; Gero A; Gawron LM; Simmons RG; Sanders JN
Am J Obstet Gynecol; 2023 Apr; 228(4):438.e1-438.e10. PubMed ID: 36427600
[TBL] [Abstract][Full Text] [Related]
15. Exploring young women's reasons for adopting intrauterine or oral emergency contraception in the United States: a qualitative study.
Kaller S; Mays A; Freedman L; Harper CC; Biggs MA
BMC Womens Health; 2020 Jan; 20(1):15. PubMed ID: 31992295
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially insured women.
De Lott LB; Moniz MH; Niziol LM; Khanna S; Musch DC; Cornblath WT
Contraception; 2023 Sep; 125():110089. PubMed ID: 37331461
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel Intrauterine Device Use in Overweight and Obese Women.
Saito-Tom LY; Soon RA; Harris SC; Salcedo J; Kaneshiro BE
Hawaii J Med Public Health; 2015 Nov; 74(11):369-74. PubMed ID: 26568900
[TBL] [Abstract][Full Text] [Related]
18. Complications and continuation of intrauterine device use among commercially insured teenagers.
Berenson AB; Tan A; Hirth JM; Wilkinson GS
Obstet Gynecol; 2013 May; 121(5):951-958. PubMed ID: 23635730
[TBL] [Abstract][Full Text] [Related]
19. Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
Kaplan J; Turok DK; Gero A; Kaiser JE; Simmons RG; Fay KE
Contraception; 2023 Feb; 118():109893. PubMed ID: 36240903
[TBL] [Abstract][Full Text] [Related]
20. Changes in uptake and cost of long-acting reversible contraceptive devices following the introduction of a new low-cost levonorgestrel IUD in Utah's Title X clinics: a retrospective review.
Roth LP; Sanders JN; Simmons RG; Bullock H; Jacobson E; Turok DK
Contraception; 2018 Jul; 98(1):63-68. PubMed ID: 29574095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
